Suneil Jolly, MD
Interventional Pain Medicine · Kenner, LANPI 1073807509
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,274 of the $107,145 with a category attached, or 61.9%. 43 manufacturers reported payments, led by Boston Scientific at 42.8% of the total. Reporting peaked in 2019 at $74,509 and has fallen 99.2% since, to $561 in 2025. Among interventional pain medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 468 payments — averaging $228.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$46K
- Daiichi Sankyo Inc.$30K
- Abbott$28K
- Nevro Corp.$398
- Medtronic$285
- Stryker$219
- plus $2K from 37 others
Across 66 payments — averaging $5426.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$358K
What the payments were for
- Consulting fees$23,74322%
- Speaking & faculty fees$66,27462%
- Travel & lodging$8,1578%
- Food & beverage$8,9728%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Morphabond ER$29,880
- SPECTRA WAVEWRITER$25,686
- Proclaim Family of SCS IPGs$20,786
- WAVEWRITER ALPHA$7,014
- GENERAL - THERAPIES$6,448
- Neuromodulation Dspsbls and Accs$3,938
- GENERAL PAIN MANAGEMENT$2,448
- WaveWriter Alpha Prime 16$2,365
- Axium INS DRG IPG$535
- PROCLAIM$157
- AUGMENT INJECTABLE$154
- Omnia$144
- Proclaim IPG$127
- PAINTEQ$120
- Senza$105
How this compares
$107,145 in reported general payments places this provider in the 95th percentile of 57 interventional pain medicine providers in Louisiana.
See all interventional pain medicine providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 150 | $2,928 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $2,329 |
| Lidocaine | 20 | $2,175 |
| Diclofenac Sodium | 42 | $1,400 |
| Tizanidine Hcl | 86 | $677 |
| Gabapentin | 56 | $661 |
| Pregabalin | 28 | $265 |
| Methocarbamol | 22 | $165 |
| Naproxen | 16 | $157 |
| Duloxetine Hcl | 14 | $137 |
| Meloxicam | 58 | $132 |
| Cephalexin | 12 | $110 |
| Tramadol Hcl | 32 | $82 |
| Cyclobenzaprine Hcl | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Kenner
- Tarun JollyKenner$263
- Maged GuirguisNew Orleans$565K
- John CefaluShreveport$71K
- Steve LeeSlidell$57K
- William WhyteShreveport$39K
- Paul HubbellMetairie$33K
- Ken EhrhardtHammond$22K
- Thomas BerryLacombe$21K
- Randall BrewerShreveport$19K
- Corey Ann ConnCovinton$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.